Aberrant activation of EGFR is seen in many solid cancers, which has led to the development EGFR-targeted anti-cancer therapies. However, epidermal growth factor receptor (EGFR) plays an important role hair morphogenesis and maintenance skin homeostasis. Therefore, cancer patients receiving inhibitors commonly develop a papulopustular rash, pruritus dry skin. Severe adverse events may require i...